Novel prophylactic and therapeutic vaccine against tuberculosis

Vaccine

Volumn 27, Issue 25-26, 2009, Pages 3267-3270

  Okada, Masaji ^a   Kita, Yoko ^a   Nakajima, Toshihiro ^b   Kanamaru, Noriko ^a   Hashimoto, Satomi ^a   Nagasawa, Tetsuji ^b   Kaneda, Yasufumi ^c   Yoshida, Shigeto ^d   Nishida, Yasuko ^a   Nakatani, Hitoshi ^a   Takao, Kyoko ^a   Kishigami, Chie ^a   Inoue, Yoshikazu ^a   Matsumoto, Makoto ^e   McMurray, David N ^f   dela Cruz, E C ^g   Tan, E V ^g   Abalos, R M ^g   Burgos, J A ^g   Saunderson, Paul ^g   Sakatani, Mitsunori ^a   more..

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b GenomIdea Inc   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^f TEXAS A AND M UNIVERSITY   (United States)

^g Leonard Wood Memorial ^*  (Philippines)

Author keywords

HSP65 + IL 12 DNA vaccine; Therapeutic effect; Tuberculosis

Indexed keywords

DNA VACCINE; HEAT SHOCK PROTEIN 65; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; IMMUNE RESPONSE; JAPAN; MOUSE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL; THERAPY EFFECT; TUBERCULOSIS; VIRUS ENVELOPE; VIRUS HEMAGGLUTINATION;

ANIMALS; ANTIGENS, CD8; BACTERIAL PROTEINS; CHAPERONINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; INTERLEUKIN-12; LUNG; MACACA FASCICULARIS; MICE; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION; VACCINES, DNA;

EID: 67349210350     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.064     Document Type: Article

References (9)

1. Yoshida S., Tanaka T., Kita Y., Kuwayama S., Kanamaru N., Muraki Y., et al. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation. Vaccine 24 (2006) 1191-1204
2. Okada M., Kita Y., Nakajima T., Kanamaru N., Hashimoto S., Nagasawa T., et al. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomologus monkey model of TB. Vaccine 25 16 (2007) 2990-2993
3. Walsh G.P., Tan E.V., dela Cruz E.C., Abalos R.M., Villahermosa L.G., Young L.J., et al. The Philippine cynomolgus monkey provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med 2 4 (1996) 430-436
4. Kita Y., Tanaka T., Yoshida S., Ohara N., Kaneda Y., Kuwayama S., et al. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Vaccine 23 (2005) 2132-2135
5. Saeki Y., Matsumoto N., Nakano Y., Mori M., Awai K., and Kaneda Y. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus). Hum Gene Ther 8 17 (1997) 2133-2141
6. Okada M., Yoshimura N., Kaieda T., Yamamura Y., and Kishimoto T. Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci USA 78 12 (1981) 7717-7721
7. Okada M., Okuno Y., Hashimoto S., Kita Y., Kanamaru N., Nishida Y., et al. Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. Vaccine 25 (2007) 3038-3040
8. Tanaka F., Abe M., Akiyoshi T., Nomura T., Sugimachi K., Kishimoto T., et al. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the interleukin-6 gene using adenovirus vector. Cancer Res 57 7 (1997) 1335-1343
9. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu Rev Immunol 19 (2001) 93-129